During the Life Sciences Baltics 2018 Carl Zeiss Microscopy established strong relationships with scientists from Vilnius Life Science University Centre and Lithuanian National Pathology Centre. Currently there are two ongoing  projects with Proteomics Centre – one of them has already helped  improving applications in cancer research.

BrachyDOSE is a Lithuanian start-up which had a spectacular year. It was recognized as one of the most promising european start-ups in healthcare innovation and received InnoStars Award powered by EIT Health. A team of experienced engineers developed a product that provides more effective and personalised cancer treatment. BrachyDOSE enables to measure radiation dose in real time at the needed organ and surroundings of tumour. It helps oncologists to provide personalised and more accurate treatment. Patients may recover faster and leave the hospital for further treatment at home. This also helps to reduce treatment expenses. They have a product prototype and are currently testing its features at The National Cancer Institute with the big hopes for 2020 to prove successful prototype testing at clinical environment and to secure finances for further development.  

Life Sciences Baltics 2020 team proposes a variety of opportunities for our possible sponsors to join the process of the forum and receive benefits. Fill in our form and we will contact with you soon to discuss flexible and tailored solutions to optimize your investment.